World

Medical journal editorial refutes WHO finding on Gilead's remdesivir for Covid-19

The release in October of the trial’s summary findings sparked a reevaluation by some of the utility of remdesivir, which was shown to shorten Covid-19 hospitals stays by five days compared with a placebo in an earlier U.S. government-run trial. Medical journal editorial refutes WHO finding on Gilead's remdesivir for Covid-19
In this file photo, an ampule of remdesivir is pictured during a news conference at the University Hospital Eppendorf (UKE) in Hamburg, Germany, April 8, 2020, as the spread of coronavirus disease (COVID-19) continues. Reuters
bookmark
Reuters
Published at : December 3, 2020
Updated at : December 3, 2020 11:07

Top